The global bowel management systems market is expected to reach US$ 2,391.4 Mn in 2026 from US$ 1,745.5 Mn in 2017, expanding at a CAGR of 3.6% from 2018 to 2026.
Market Insights
Inflammatory bowel disease such as ulcerative colitis and Crohn’s disease has symptoms of abdominal pain, bloody stool and gut mucosal inflammation. Irritable bowel syndrome and Crohn’s disease is an idiopathic disease which has no underlying causative agent but if once triggered can cause severe constipation or diarrhea due to altered peristaltic activity. Fecal incontinence is growing rapidly in both adult and pediatric patients worldwide.
Colostomy bags will be the fastest and largest growing product during the forecast period. Its dominance is determined by its low maintenance cost incurred, cleanliness and hygiene maintained during disposal of stool. Irrigation systems are still in practice since ages due to its benefit in body detoxification and immediate relief achieved in episodes of chronic constipation in pediatric patients. Sacral nerve modulation devices are employed to treat fecal incontinence in disabled and paralyzed patients.
The adult patient population are presently leading the patient type segment for bowel management systems market on account of the rising prevalence of irritable bowel syndrome, stress, and unhealthy eating habits. Pediatric patients will capture the market in the near future on account of genetic predisposition, environmental impact and decreased immune response of gut mucosal lining to gut microflora.
Home care settings are reigning the end-user segment for bowel management systems market. Low maintenance cost incurred and increasing demand from the elderly population drive the market growth for home care settings. Hospitals and ambulatory surgery centers have shown remarkable growth in remote locations due to the prevalence of untreated population suffering from intestinal disorders.
North America is the clear leader in global bowel management systems market with a share of 35.6%. The primary features responsible for the affluent growth in the North American region is a growing prevalence of fecal incontinence in the elderly population and the existence of key players such as C.R.Bard, Inc., Medtronic, Plc, and B.Braun Melsungen AG etc., Europe with a share of 30.4 % is the second largest regional market on account of increasing number of patients suffering from inflammatory bowel disease and favorable reimbursement scenario for bowel management products. The Asia Pacific currently holds a market share of 18.9% owing to rampant growth in medical tourism and a significant rise in hospitals and ambulatory surgery centers providing bowel management and treatment.
Market leaders existing in bowel management systems market are Aquaflush Medical Limited, ConvaTec Group, Plc., Axonics Modulation Technologies, C.R.Bard, Inc., B.Braun Melsungen AG., Cogentix Medical, Inc., Coloplast A/S, 3M Healthcare, Medtronic, Plc. and Mederi Therapeutics, Inc.
Key Market Movements
This product will be delivered within 2 business days.
Market Insights
Inflammatory bowel disease such as ulcerative colitis and Crohn’s disease has symptoms of abdominal pain, bloody stool and gut mucosal inflammation. Irritable bowel syndrome and Crohn’s disease is an idiopathic disease which has no underlying causative agent but if once triggered can cause severe constipation or diarrhea due to altered peristaltic activity. Fecal incontinence is growing rapidly in both adult and pediatric patients worldwide.
Colostomy bags will be the fastest and largest growing product during the forecast period. Its dominance is determined by its low maintenance cost incurred, cleanliness and hygiene maintained during disposal of stool. Irrigation systems are still in practice since ages due to its benefit in body detoxification and immediate relief achieved in episodes of chronic constipation in pediatric patients. Sacral nerve modulation devices are employed to treat fecal incontinence in disabled and paralyzed patients.
The adult patient population are presently leading the patient type segment for bowel management systems market on account of the rising prevalence of irritable bowel syndrome, stress, and unhealthy eating habits. Pediatric patients will capture the market in the near future on account of genetic predisposition, environmental impact and decreased immune response of gut mucosal lining to gut microflora.
Home care settings are reigning the end-user segment for bowel management systems market. Low maintenance cost incurred and increasing demand from the elderly population drive the market growth for home care settings. Hospitals and ambulatory surgery centers have shown remarkable growth in remote locations due to the prevalence of untreated population suffering from intestinal disorders.
North America is the clear leader in global bowel management systems market with a share of 35.6%. The primary features responsible for the affluent growth in the North American region is a growing prevalence of fecal incontinence in the elderly population and the existence of key players such as C.R.Bard, Inc., Medtronic, Plc, and B.Braun Melsungen AG etc., Europe with a share of 30.4 % is the second largest regional market on account of increasing number of patients suffering from inflammatory bowel disease and favorable reimbursement scenario for bowel management products. The Asia Pacific currently holds a market share of 18.9% owing to rampant growth in medical tourism and a significant rise in hospitals and ambulatory surgery centers providing bowel management and treatment.
Market leaders existing in bowel management systems market are Aquaflush Medical Limited, ConvaTec Group, Plc., Axonics Modulation Technologies, C.R.Bard, Inc., B.Braun Melsungen AG., Cogentix Medical, Inc., Coloplast A/S, 3M Healthcare, Medtronic, Plc. and Mederi Therapeutics, Inc.
Key Market Movements
- The rising prevalence of inflammatory bowel disease and fecal incontinence worldwide
- Favorable reimbursement scenario for colostomy bags and irrigation systems in developed regions
- Technical innovation in sacral nerve stimulation devices to facilitate stool excretion in disabled and paralyzed patients
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Preface
Chapter 2. Executive Summary
Chapter 3. Bowel Management Systems Market: Dynamics and Future Outlook
Chapter 4. Global Bowel Management Systems Market, by Product
Chapter 5. Global Bowel Management Systems Market, by Patient Type
Chapter 6. Global Bowel Management Systems Market, by End-User
Chapter 7. Global Bowel Management Systems Market, by Geography
Chapter 8. Company Profiles
List of Figures
List of Tables
Companies Mentioned
- Aquaflush Medical Limited
- Axonics Modulation Technologies
- B.Braun Melsungen AG
- C.R.Bard, Inc.
- Cogentix Medical, Inc.
- ConvaTec Group, Plc.
- Coloplast A/S
- 3M Healthcare
- Medtronic, Plc.
- Mederi Therapeutics, Inc.
